Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline.
HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation.
CellCept (Product Insert)
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.
Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin.
When global rating of change contradicts observed change: Examining appraisal processes underlying paradoxical responses over time.
Selective and compartmentalized myelin expression of HspB5.
Thermal patterns in zoster.
Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
Assessing the criterion validity of four highly abbreviated measures from the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis.
[Evaluation of white matter myelination in preterm infants using DTI and MRI].
Experimental Research on Differentiation-Inducing Growth of Nerve Lateral Bud by HUC-MSCs Chitosan Composite Conduit.
Autoimmune Myopathies: Where Do We Stand?
The restoration of conduction by central remyelination.
Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair.
Physical activity and the incidence of multiple sclerosis.
Changes in Multidigit Synergies and Their Feed-Forward Adjustments in Multiple Sclerosis.
Clinical Features and Visual Outcomes of Optic Neuritis in Chinese Children.
[Panuveitis with oral and genital ulcer misdiagnosed as Behcet's disease: two cases report and literature review].
Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29.
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.
Comparison of two quantitative proton density mapping methods in multiple sclerosis.
"Gait responder" to fampridine, a too restrictive concept?

Pages